Given the recent business and sociopolitical environments, having the right business model is critical to successfully entering the China pharmaceuticals market.
In this webinar, we will share relevant examples regarding how other life science companies responded to the various business environmental changes in China and discuss how European pharmaceutical companies can enter the China market successfully by leveraging newer pathways.
View the recording to hear our experts:
- Highlight the recent pricing and access trends in China in pharma
- Introduce innovative routes to expedite launch and access
- Share experiences of companies that adopted these pathways to launch innovative therapies, highlighting the benefits and the challenges
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…